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Abstract
Introduction
The use of complementary and alternative medicine
(CAM) in the United States has been rising steadily, espe-
cially among people with chronic conditions such as
osteoarthritis. It has been suggested that ethnicity and
acculturation may influence use of CAM. The purpose of
this study was to assess the influence of ethnicity and
acculturation on patterns of CAM use among Hispanic and
non-Hispanic white adults with osteoarthritis.
Methods
We conducted interviews in person, in English or
Spanish, using a 255-item survey. We randomly selected
participants aged 18 to 84 years from patients at universi-
ty-based primary care outpatient clinics who had been
diagnosed with osteoarthritis during the previous year.
Measures included prevalence and types of CAM use,
sociodemographic factors, self-reported ethnicity, and
degree of acculturation according to language use.
Results
The Hispanic (n = 218) and non-Hispanic white (n = 204)
populations showed similar rates of overall current CAM
use (65.5% Hispanic vs 67.8% NHW) at time of interview.
However, although more Hispanics used oral herbs (P =
.03) and magnets or copper jewelry (P = .03), more non-
Hispanic whites used nutritional supplements (P < .001).
Hispanics speaking primarily English mirrored patterns of
CAM use among non-Hispanic whites. These effects per-
sisted after controlling for age, sex, income, education,
degree of disability, and disease duration.
Conclusion
In this population, ethnicity was a significant influence
on patterns of CAM use but did not affect overall rates of
use. Some differences were more pronounced among
Spanish-speaking Hispanics, reflecting the incorporation of
folk or traditional remedies into their health care practices.
Introduction
Complementary and alternative medicine (CAM)
describes a broad category of health care practices that are
not currently a part of conventional Western medicine (1).
From 1990 to 1997, the number of individuals reporting
the use of CAM within the previous year increased from
34% to 42% (2), and a recent national study found that 62%
of telephone survey respondents had used some CAM ther-
apy within 12 months of the survey (3). Several explana-
tions have been proposed for the apparent surge in CAM
popularity, including dissatisfaction with our current
health care system, a failure of conventional treatments or
an attempt to avoid drug side effects, a desire for more per-
sonal control over health care decisions, the influence of
our society’s recent focus on health promotion and disease
prevention, and the impact of family or cultural back-
ground (2-7).
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Although some studies of primary care patients have
charted increased CAM use among young, white, well-
educated, and more economically secure populations (2-
4,8-10), other research has pointed out that CAM use is
also high among low-income or rural groups, highlight-
ing again the variety of reasons for which individuals
may use CAM (2,3,5,11). Wootton and Sparber suggest-
ed a bimodal distribution of CAM use, in which higher-
income groups use disposable income for CAM products
and services that supplement their standard health care
and ethnic minority and lower-income groups use tradi-
tional healing as a substitute for conventional care (11).
The evolution of medical practices among ethnic minori-
ties is seen as part of the larger process of socialization
within U.S. culture; the socialization process has also
been labeled acculturation as the values, behaviors, and
norms of individuals within ethnic minorities are gradu-
ally modified through exposure to a new culture. Degree
of acculturation may potentially influence patterns of
medical care (12). Folk remedies, defined loosely as
layperson’s medicine, seem to be used largely in ethnic
minority populations, with frequency of use related
inversely to level of acculturation (4,12). Among ethnic
minority populations, Hispanics appear to use tradition-
al or folk remedies — most commonly home or self-care
practices — significantly more often than other minority
groups (4,12). Still, in light of the scarcity of research on
patterns of CAM use among ethnic minorities, it has
been difficult to determine trends and CAM modalities
specific to Hispanic populations.
It has been suggested that chronic musculoskeletal con-
ditions provide an ideal framework in which to research
CAM use because they are prevalent, have no known cure,
are characterized by chronic pain, and often adversely
affect normal function (13); they are also among the most
frequently cited reasons for using CAM (2-4,7,8,14,15).
Osteoarthritis  is the most prevalent of these conditions
(16). Few studies, however, have surveyed patterns of
CAM use among the osteoarthritis population, and fewer
still have investigated variations of CAM use among dif-
ferent groups within the osteoarthritis population
(8,15,17-20).
This study documented patterns of use of CAM therapies
among adults with osteoarthritis in a New Mexico primary
care clinic population to assess whether there were signif-
icant differences in CAM use between Hispanics and non-
Hispanic whites (NHWs) and whether ethnic variations
were influenced by level of acculturation, socioeconomic
status, and education.
Methods
Sample selection and recruitment
The individuals included in this study were part of a
larger study of CAM use (21). The population included all
patients aged 18 to 84 years who visited one of six primary
care clinics of the University of New Mexico Hospital sys-
tem in Albuquerque, NM, from June 2000 through May
2001 and were diagnosed with osteoarthritis, rheumatoid
arthritis, or fibromyalgia. We randomly selected partici-
pants within categories of diagnosis, sex, and ethnic group
(Hispanic and NHW) from the hospital outpatient man-
agement database. To obtain more Hispanics, more men,
and more rheumatoid arthritis participants, patients in
these categories were sampled at higher rates than NHW
women with diagnoses of osteoarthritis or fibromyalgia.
The sampling strata were based on the clinic-assigned eth-
nicity and diagnostic group, although self-reported ethnic-
ity is used in the analysis.
Of 1210 eligible patients, 612 (50.6%) participated in the
larger study (21). Study participants and nonparticipants
were similar in sex and age but differed in ethnicity and
clinic diagnosis. The response rate among participants
with clinic-designated Hispanic ethnicity (45%) was signif-
icantly lower than among NHWs (55%) (P < .001), and
patients with rheumatoid arthritis were significantly more
likely to participate than patients with osteoarthritis (P =
.006). Among the 612 participants, 42% had a clinic desig-
nation of Hispanic ethnicity, which was significantly lower
than the 48% self-reported prevalence of Hispanic ethnici-
ty (P < .001 by McNemar’s test). The crude agreement
between clinic and self-reported ethnicity was 89.9% with
a κ value of 79.6. For this paper, patients with clinic diag-
noses of rheumatoid arthritis (n = 95) and self-reported
fibromyalgia (n = 95) were excluded, and the analysis was
limited to those with osteoarthritis (n = 422).
After patients were selected from the clinic database, we
obtained active written consent to contact them from their
primary-care provider and then mailed them an invitation
to complete an in-person interview. Trained interviewers
followed up the introductory letters with telephone calls in
English or Spanish, inviting individuals to participate and
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participants had to self-identify as Hispanic or NHW and
speak either English or Spanish. Potential participants
were informed that the interview would ask about ways
they managed their arthritis on their own, beyond what
their primary care provider prescribed and recommended;
the explanation did not use CAM terminology. The inter-
view took an average of 45 minutes to complete. Eligible
individuals signed an informed consent form just before
their interview. This study received approval from the
institutional review board at the University of New Mexico
Health Sciences Center.
Survey instrument
We developed the survey instrument after an extensive
literature review, a review of previous surveys of CAM use,
consultation with Centers for Disease Control and
Prevention (CDC) staff, and focus group interviews. We
designed the survey to elicit information on CAM use for
arthritis only. We used the Behavioral Risk Factor
Surveillance System and Quality of Life questionnaires
(22,23) to assess demographic information, self-reported
type of arthritis, perceived health status, and comorbidi-
ties. We used the Stanford Health Assessment
Questionnaire (HAQ) (24) to measure functional ability,
the five-item Arthritis Helplessness Index (25) to address
perceived ability to manage arthritis (25), a four-item med-
ical skepticism scale (26) to assess attitudes toward con-
ventional medical therapy, and the Wong-Baker Faces
Pain Scale to assess pain (27). We also included scales
evaluating fatigue and sleep problems (28,29). Finally, to
measure acculturation, we used a five-item scale to evalu-
ate the extent to which Spanish and English were used in
day-to-day life. The scale was extrapolated from a 12-item
scale assessing language use, media preferences, and eth-
nic social relations (30). Marin et al found that the five-item
language scale correlated strongly with the Mexican
American and Central American respondents’ generation
in the United States, length of U.S. residence, age at arrival
in the United States, ethnic self-identification, and an inde-
pendent acculturation index (30). The use of prayer as a
CAM strategy to manage osteoarthritis, although asked in
the questionnaire, was excluded from the analyses because
subjects were unable to distinguish between prayer for
overall health and for osteoarthritis management.
Prevalidated Spanish translations were used for the
HAQ (31); demographic, health status, and comorbidity
items (22); Arthritis Helplessness Index (32); and accul-
turation measures (30). The remainder of the survey was
translated by a Mexican-born translator, edited by two
bilingual interviewers to ensure comprehension by non-
Mexican Spanish-speakers, and back-translated to
English by a bilingual health researcher to ensure equiva-
lent meaning. We piloted the Spanish version among sev-
eral adults with arthritis who were known to the
researchers and who were not in the study sample and
then made minor revisions.
Data collection
During 2001 and 2002, trained interviewers conducted
in-person interviews in English or Spanish in a private
room either in the participant’s home or in one of the uni-
versity clinics. Interviewers asked each survey question
and then entered the participant’s answers directly into a
laptop-computer database; study staff then rechecked, ver-
ified, and exported data to permanent SAS (SAS Institute
Inc, Cary, NC) files for cleaning, reporting, and analysis.
Statistical analysis
We computed sampling fractions for each diagno-
sis–sex–ethnicity stratum as the ratio of the number of
participants that completed an interview to the total
number of clinic patients in the stratum. Differences
between Hispanic and NHW populations were deter-
mined by Pearson chi-square test or Wilcoxon test.
Each observation was weighted by the inverse of the
appropriate sampling fraction, the Horvitz–Thompson
weight, to obtain estimates of proportions, means, and
odds ratios (ORs) for the target clinic population.
SUDAAN version 9.0 (Research Triangle Institute,
Research Triangle Park, NC) was used for all analyses.
A stratified sampling with replacement design was
specified, and sampling weights were assigned as
described previously. Unless otherwise stated, it should
be assumed that any reported statistic, other than sam-
ple size, is weighted to the target population.
Results
Group characteristics and demographics
Of the total clinic population with osteoarthritis, 51.6%
were Hispanic, and 48.3% were NHW. The Hispanic popu-
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lation did not represent a homogenous group. Most indi-
viduals within this group were born in the United States
(86.3%) and described themselves mainly as Spanish
American (78.8%) or Mexican American (14.5%). Of those
born in Mexico (11.2%), all described themselves as
Mexican or Mexican American. Only 2.5% were born in a
country other than the United States or Mexico. Of these,
two individuals self-identified as Central American and
four as Cuban American.
Table 1 shows participant demographics for the entire
sample and stratified by ethnicity. The Hispanic clinic
population with osteoarthritis had significantly lower
levels of education (P < .001) and lower annual house-
hold income (P < .001) than NHWs. Hispanic partici-
pants reported significantly higher (P < .001 for each)
pain levels in the week before the interview, more mobil-
ity limitations, and less confidence in their ability to
manage their arthritis than NHWs.
We further described Hispanic participants by accul-
turation. Language acculturation scores ranged from 5
(speaking, reading and thinking in Spanish only) to 25
(using English only) with a median of 15 on Marin’s 5-
item language use scale (30). Hispanics were classified
as low-acculturated if they scored at or below the medi-
an, and as high-acculturated if they scored above the
median. The median was set as a cut-off point for this
study. As shown in Table 2, half (51%) of the Hispanic
participants with osteoarthritis scored as high-accultur-
ated, meaning they used English more than Spanish in
day-to-day life, and half (49%) scored as low-acculturat-
ed, meaning they used Spanish more than English.
High-acculturated Hispanic osteoarthritis patients were
more likely to be women, to be less than 55 years old,
and to have completed high school. Low-acculturated
Hispanic osteoarthritis patients were more likely to
report higher pain (P = .004) and disability levels (P =
.002) and to report less confidence in their ability to
manage their arthritis (P = .005).
Differences between Hispanics and NHWs in patterns of
current CAM use
The vast majority (89.4%) of the osteoarthritis clinic pop-
ulation had ever used CAM, and 66.7% showed current use
of CAM (data not shown). We chose current use of CAM
therapies, defined as use at the time of the participant
interview, as a more meaningful marker than ever used in
these analyses, because ever used included therapies that
were tried only once or twice and then abandoned. As
shown in Table 3, similar rates of current CAM use were
observed for the two ethnic groups (65.5% for Hispanics
and 67.8% for NHWs). However, Hispanics and NHWs
varied in the kinds of CAM used. NHWs were significant-
ly more likely to use nutritional supplements (P < .001),
especially glucosamine, chondroitin, and flaxseed oil, than
Hispanics. Significantly more Hispanics used oral herbs (P
= .03), specifically garlic, and items worn, such as copper
jewelry and magnets (P = .03), than did NHWs.
Differences between groups of Hispanics by level of accul-
turation
We further differentiated patterns of CAM use among
the Hispanic population by level of acculturation as
measured by the 5-item language-use scale. As shown in
Table 4, low-acculturated Hispanics (66.0%) and high-
acculturated Hispanics (65.1%) had similar overall rates
of current CAM use. However, low-acculturated
Hispanics were significantly more likely to use oral
herbs (P = .03) and topical herbal rubs (P = .048) and less
likely to use movement therapies (P = .009) than high-
acculturated Hispanics.
Logistic regression models for CAM use
Logistic regression modeling was undertaken to
remove the potentially confounding effects of age, sex,
education, income, duration of disease, pain, disability,
arthritis helplessness, and medical skepticism from the
crude association of ethnicity and CAM use. Ethnicity
was categorized as NHW, low-acculturated Hispanic, or
high-acculturated Hispanic. Table 5 presents the results
as ORs with 95% confidence intervals (CIs), comparing
low-acculurated and high-acculturated Hispanics as well
as each group of Hispanics with NHWs. Although the
general pattern of differences was similar to the crude
differences shown in Tables 3 and 4, the pattern of sta-
tistically significant effects was somewhat different.
High-acculturated Hispanics were more similar to
NHWs in their use of most types of CAM than they were
to low-acculturated Hispanics. Compared with NHWs,
low-acculturated Hispanics had significantly higher use
of oral herbs (P = .006) and items worn (P = .01),
although high-acculturated Hispanics did not have high-
er use of oral herbs (P = .44) or items worn (P = .93).
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Table 6 shows that Hispanics (52.2%) were significantly
less likely than NHWs (75.2%) to report their CAM use to
their primary care provider (P < .001). We asked the par-
ticipants open-ended questions about why they told or did
not tell their provider about CAM use and how the
provider reacted. We then grouped, labeled, and coded
responses for quantitative frequency counts. Only respons-
es given by at least 6% of one of the two ethnic groups are
shown in Table 6. In both ethnic groups, the key to CAM
use disclosure or nondisclosure was whether or not
providers directly asked about CAM use. NHWs were more
likely to report a supportive reaction from their provider
than Hispanics (P = .007).
Other results
Both ethnic groups had similar reasons for using
CAM, although NHWs (5.0%) were more likely than
Hispanics (0.4%) to say they preferred CAM to use of
standard Western medications (P = .01). NHWs (7.8%)
were also more likely than Hispanics (2.6%) to say that
CAM improved their mobility (P = .04) (data not
shown). For both Hispanics and NHWs, the primary
reasons cited for using CAM related to pain relief; both
groups were also interested in preventing disease pro-
gression or were willing to try CAM therapies to see if
they were effective. CAM use did not change the use of
standard medical therapies of most Hispanics (85.7%)
or NHWs (85.4%) (data not shown). Of participants in
both groups who reported a change in medical thera-
pies, respondents primarily believed they would use
fewer medications or be able to blend their CAM use
with more standard medical therapies.
Discussion
One of the most striking findings of this survey was the
confirmation of high rates of overall use of CAM therapies
for managing osteoarthritis among both Hispanics and
NHWs with low- to mid-level incomes in a primary care
setting. Most (89.4%) participants reported ever having
used CAM, and 66.7% reported current use of CAM for
osteoarthritis management, even after excluding high-
response items, such as prayer, from the analyses. These
rates are higher than most that have been reported in the
literature. Barnes et al showed current rates of CAM use
(for any purpose, including prayer) close to 62%, with life-
time use rates of 75% (3). Other surveys of CAM use have
reported rates of current CAM use from 21% to 43%
(4,7,9,33); higher rates of current use (34% to 66%) have
been found in surveys of individuals with arthritis
(8,13,14,17-20,34). New Mexico has a reputation for being
alternative-health care friendly, which may help explain
the numbers reported in this study. There are many alter-
native medicine practitioners in the Albuquerque area,
and many people of different backgrounds and health care
philosophies reside in this region. The environment also
may contribute to the normalization of CAM practices and
subsequent openness in discussing use of CAM therapies
with primary care providers. Finally, the personal nature
of the one-on-one interviews in this study may also have
contributed to a more comfortable atmosphere and thus
more honest revelations of CAM use.
Both Hispanics and NHWs in this population had simi-
lar rates of overall CAM use. Previous research has shown
a range of 41% to 58% in overall rates of current CAM use
among Hispanics (33,35-37). The high rates of use among
Hispanics in this study can be explained in part by recog-
nizing that our research focused on individuals with
arthritis, who tend to report higher rates of CAM use over-
all. In contrast to our data, recent studies have shown
higher rates of CAM use among Hispanics than among
other ethnic groups, leading investigators to conclude that
folk remedies or traditional healing practices are used
more often in the Hispanic community (35,36). The simi-
larity in rates of use of any type of CAM that we observed
between the two ethnic groups may reflect higher than
usual rates of CAM use among the NHW population.
Despite similar overall rates of CAM use, patterns of
CAM use varied by ethnicity. After modeling to account for
ethnic differences in demographics and disease status, we
found that more low-acculturated Hispanics used oral
herbs and wore items to manage their osteoarthritis than
NHWs and that more high-acculturated Hispanics used
energy therapies than NHWs. Previous research found
that Hispanics were more likely to use traditional healing
methods, often in the form of herbal preparations
(33,35,36). It would make sense that degree of proximity to
a parent culture would affect the degree of parent cultural
influence on health care practices. This idea is supported
by our findings that patterns of CAM use among high-
acculturated Hispanics largely mirrored patterns among
NHWs. On the other end of the spectrum, low-acculturat-
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ed Hispanics were more likely than NHWs to use herbs,
magnets, and copper jewelry. Although we controlled for
the influence of age, sex, income, education, and disease
status on CAM use, we did not control for other aspects
influencing CAM use such as access to CAM services and
products. Higher rates of use of herbal preparations and
items worn among Spanish-speakers may be supported by
a tradition of self-medication practices common in Central
America, easy access to CAM products across the border in
Mexico, the traditionally lower cost of gathered herbs, and
the high degree of influence of family members and oral
tradition on Hispanic health care practices (4,11,35,36).
However, rates of overall CAM use among Hispanics in
this study were not influenced by level of acculturation.
Few studies have examined the influence of acculturation
on CAM use; in Najm’s study of the ethnic elderly, howev-
er, recent immigration status was predictive of CAM use
among Hispanics (35).
Finally, these data reinforce the idea that communica-
tion between patients and primary care providers about
the use of complementary therapies depends largely on
whether the providers directly ask about CAM use.
Although most participants from both ethnic groups
reported telling their primary care provider about their
CAM use, significantly fewer Hispanics (52.2%) did so
than NHWs (75.2%). Furthermore, although Hispanics
were less likely to communicate their CAM use to their
primary care provider, they were also less likely to view
their provider’s response as supportive. These findings are
fairly consistent with previous research showing that up
to 66% of Hispanics never discuss their CAM use with
their primary care provider (37). However, communica-
tion is not a problem limited to the Hispanic population;
25% of NHWs in this study and up to 83% of participants
in other studies did not reveal their CAM use to their pri-
mary care provider (2,35,38). To a large extent, this lack
of communication may be attributed to a don’t-ask–don’t-
tell attitude, as first suggested by Eisenberg in 1998 and
supported in subsequent literature (2,38). It is possible
that patient–provider communication practices about
CAM use may have shifted in the 4 years since these data
were collected.
This study is not without its weaknesses or limitations.
The data were derived from personal recollections of CAM
use and are thus subject to recall bias. Recall bias may
affect the accuracy of memory for types and frequency of
use of CAM modalities, but more importantly it may blur
the distinction between CAM use for arthritis and CAM
use for general health maintenance or treatment of con-
current ailments. We hope that a focus on current use of
CAM therapies may have avoided some of this effect. Also,
osteoarthritis diagnosis was not confirmed by medical
record review, so it is possible the sample included some
individuals with chronic joint pain but without true
osteoarthritis. The question may be raised of whether the
five-question language-use scale, selected for a balance of
convenience and validity, represents a true measure of
acculturation. A process as complex and multifactorial as
the assimilation of new cultural practices into an older tra-
dition would be difficult to condense into any survey, let
alone a short scale that only assessed use of the Spanish
and English languages.
Generalizability of the study is limited for several rea-
sons. As stated above, Albuquerque is a CAM-friendly
area, so CAM use is likely to be higher in Albuquerque
than in other regions. The information presented here was
collected from a clinic-based population recruited from a
single health care organization and may not be represen-
tative of other clinic populations. We do not know language
acculturation levels in the regional Hispanic population
and so cannot compare the acculturation results to a larg-
er Hispanic population. We had low response rates overall,
with a moderate difference in response rates between
Hispanics and NHWs. However, nonparticipants were sta-
tistically similar to participants in sex and age. Finally, as
is true of any research conducted regionally, findings
gleaned from this Hispanic population are not necessarily
applicable to Hispanics elsewhere because of the wide het-
erogeneity of Hispanic populations in this country. Even if
generalizability were compromised, the conclusion stands
that patterns of CAM use for osteoarthritis management
may vary among subgroups in ways that cannot be
assumed, and therefore it is important for providers to
directly ask about CAM use, regardless of the patient’s
background.
These data analyses reinforce the understanding that
individuals of different ethnic and socioeconomic back-
grounds are using CAM at high rates. Although in the cur-
rent study, acculturation and ethnicity appear to influence
the forms of CAM that might be used, they do not seem to
influence overall rates of use. In other words, we cannot
make assumptions about who is and is not using alterna-
tive therapies based solely on an individual’s cultural back-
ground. We are now seeing more research into the safety
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allowing us to formulate increasingly clear-cut recommen-
dations and treatment guidelines for CAM modalities.
However, even if we are not able to provide our patients
with specific recommendations, we must continue to mon-
itor which therapies they are using on their own. It is clear
that individuals are still not likely to disclose their use of
CAM therapies in the absence of a direct question, and
Hispanics may be more reluctant than NHWs to discuss
their CAM use. In the end, it is the ethical obligation of the
health care provider to ask patients about their use of
CAM not only to facilitate an open patient–provider rela-
tionship but also to avoid possible drug–herb interactions
and to provide guidance. Finally, as suggested in the 2004
summary on patterns of CAM use in the United States (6),
we should continue to investigate where people are learn-
ing about CAM and take steps to improve the complete-
ness and reliability of available information about CAM
therapies.
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Tables
Table 1. Characteristics of Primary Care Patients With Osteoarthritis in University-based Outpatient Clinics in Albuquerque,
NM, 2001–2002, Percentages Weighted by Inverse of Sampling Fraction
Sex, %
Female 66.6 65.6 67.5 .46
Male 33.4 34.4 32.5
Age, %
18-54 y 21.5 20.8 22.1 .47
55-64 y 34.9 37.9 32.1
65-74 y 27.9 28.2 27.6
75-84 y 15.7 13.0 18.2
Education, %
Did not graduate from high school 28.9 53.0 6.7 <.001
High school graduate or graduate equivalency degree 19.5 23.5 15.9
Some college 21.9 12.3 30.7
College graduate 29.5 10.7 46.7
Unknown 0.2 0.4 0
Annual household income, %
<$25,000 64.4 83.9 46.6 <.001
$25,000–$50,000 18.2 5.4 29.9
>$50,000 12.8 4.0 20.8
Refused or unknown 4.6 6.7 2.7
Duration of disease, y, weighted mean 12.6 11.3 13.7 .04
Pain indexb, weighted mean 5.3 6.1 4.7 <.001
Disability indexc, weighted mean 1.0 1.2 0.9 <.001
Arthritis Helplessness Indexd, weighted mean 13.2 14.9 11.9 <.001
Medical skepticism scalee, weighted mean 12.5 12.4 12.6 .66
aP values were determined by Pearson chi-square test or Wilcoxon test.
bThe Wong-Baker Faces Pain Scale (27) was used to assess pain on a scale of 0 to 10, with 10 indicating greatest pain.
cThe Stanford Health Assessment Questionnaire (24) was used to measure functional ability on a scale of 0 to 3, with 3 indicating greatest disability.
dThe Arthritis Helplessness Index (25) was used to measure perceived ability to manage one’s arthritis on a scale of 5 to 25, with 25 representing greatest
helplessness.
eFiscella’s medical skepticism scale (26) was used to measure attitudes toward conventional medical therapy on a scale of 4 to 20, with 20 representing
greatest skepticism.
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Total Sample Hispanic Non-Hispanic White
Characteristic (n = 422) (n = 218) (n = 204) P ValueaTable 2. Characteristics of Low-Acculturateda and High-Acculturated Hispanics Among Hispanic Outpatient Clinic Patients
With Osteoarthritis in Albuquerque, NM, 2001–2002, Percentages Weighted by Inverse of Sampling Fraction
Sex, %
Female 58.4 72.6 .03
Male 41.6 27.4
Age, %
18-54 y 12.1 29.8 .01
55-64 y 39.6 38.9
65-74 y 31.2 21.2
75-84 y 17.1 10.1
Education, %
Did not graduate from high school 69.4 36.5
High school graduate or graduate equivalency degree 16.3 31.3 <.001
Some college 6.8 17.6
College graduate 6.6 14.5
Unknown 0.8 0.0
Annual household income, %
<$10,000 42.8 40.8 .15
$10,000-$15,000 28.9 23.1
$15,000-$25,000 11.5 21.1
>$25,000 7.8 11.6
Refused or unknown 8.9 3.4
Duration of disease, y, weighted mean 11.2 11.2 .98
Pain indexc, weighted mean 6.6 5.6 .004
Disability indexd, weighted mean 1.4 1.1 .002
Arthritis helplessness indexe, weighted mean 16.0 14.1 .005
Medical skepticism scalef, weighted mean 12.7 12.2 .25
aAcculturation status was determined using a five-item scale that measured the extent of use of Spanish, English, or both languages in day-to-day life.
Acculturation scores ranged from 5 (speaking, reading, and thinking in Spanish only) to 25 (speaking, reading, and thinking in English only) with a median of
15. Hispanics were classified as low acculturated if they scored at or below the median, and as high acculturated if they scored above the median.
bP values determined by Pearson chi-square test or Wilcoxon test. 
cThe Wong-Baker Faces Pain Scale (27) was used to assess pain on a scale of 0 to 10, with 10 indicating greatest pain. 
dThe Stanford Health Assessment Questionnaire (24) was used to measure functional ability on a scale of 0 to 3, with 3 indicating greatest disability. 
eThe Arthritis Helplessness Index (25) was used to measure perceived ability to manage one’s arthritis on a scale of 5 to 25, with 25 representing greatest
helplessness. 
fFiscella’s medical skepticism scale (26) was used to measure attitudes toward conventional medical therapy on a scale of 4 to 20, with 20 representing
greatest skepticism.
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Table 3. Estimates of Current Use of Complementary and Alternative Medicine (CAM) by Ethnic Group Among Primary Care
Patients with Osteoarthritis, Albuquerque, NM, 2001–2002, Percentages Weighted by Inverse of Sampling Fraction
Any CAM 65.5 67.8 .63
Nutritional supplements
Any type 25.3 42.4 <.001
Glucosamine 15.4 34.1 <.001
Chondroitin 11.2 24.0 .001
MSM (methylsulfonylmethane) 3.6 5.5 .33
Flaxseed oil 0.0 3.6 .007
Vinegar 6.4 2.8 .10
Fish oil 1.8 4.2 .17
Vitamins and minerals
Any type 12.4 11.8 .85
Vitamin C 6.5 2.0 .03
Vitamin E 4.4 4.2 .91
Magnesium 2.9 3.9 .497
Vitamin B12 2.5 3.7 .60
Oral Herbs
Any type 14.0 6.6 .03
Garlic 7.6 1.5 .005
Topical herbal rubs
Any type 26.7 19.8 .10
Tiger balm 5.0 5.2 .95
Volcanico 5.0 0.4 .005
Capsaicin cream 4.3 4.8 .82
Items worn
Any type 11.5 5.4 .03
Magnets 6.2 3.0 .13
Copper jewelry 5.7 2.8 .16
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Hispanic,  Non-Hispanic White,  Pearson Chi-Square
CAM Therapya Weighted % Weighted % P Value
aTable shows only modalities used by at least 3% of one of the two ethnic groups. (Continued on next page)Mind-body therapies
Any type 20.0 27.1 .12
Relaxation techniques 6.3 13.4 .03
Meditation 8.1 12.0 .22
Breathing techniques 5.8 10.7 .09
Sing or play instrument 7.7 4.9 .26
Visualization 6.1 7.4 .64
Energy therapies
Any type 9.1 6.2 .30
Acupressure 3.9 1.1 .09
Movement therapies
Any type 6.1 10.6 .13
Yoga 1.6 7.9 .008
CAM therapists
Any type 6.9 8.4 .57
Massage therapists 3.5 6.0 .24
Dietary approaches
Any type 4.8 7.9 .24
aTable shows only modalities used by at least 3% of one of the two ethnic groups.
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Table 3. (continued) Estimates of Current Use of Complementary and Alternative Medicine (CAM) by Ethnic Group Among
Primary Care Patients with Osteoarthritis, Albuquerque, NM, 2001–2002, Percentages Weighted by Inverse of Sampling
Fraction
Hispanic,  Non-Hispanic White,  Pearson Chi-Square
CAM Therapya Weighted % Weighted % P ValueVOLUME 3: NO. 3
JULY 2006
Table 4. Estimates of Current Use of Complementary and Alternative Medicine (CAM) by Acculturation Statusa Among
Hispanic Primary Care Patients With Osteoarthritis, Albuquerque, NM, 2001–2002, Percentages Weighted by Inverse of
Sampling Fraction
Category of CAM
Any CAM 66.0 65.1 .89
Nutritional supplements 24.9 27.4 .67
Vitamins and minerals 14.7 9.5 .28
Oral herbs 20.1 9.1 .03
Topical herbal rubs 33.1 20.8 .048
Items worn 13.7 8.3 .24
Mind-body therapies 16.3 23.5 .20
Energy therapies 6.0 12.8 .11
Movement therapies 1.8 10.7 .009
CAM therapists 8.0 6.2 .62
Dietary approaches 7.0 3.0 .21
aAcculturation status was determined using a five-item scale that measured the extent of use of Spanish, English, or both languages in day-to-day life.
Acculturation scores ranged from 5 (speaking, reading, and thinking in Spanish only) to 25 (speaking, reading, and thinking in English only) with a median of
15. Hispanics were classified as low acculturated if they scored at or below the median, and as high acculturated if they scored above the median.
Table 5. Logistic Regressiona of Acculturationb on Odds of Current Use of Complementary and Alternative Medicine (CAM)
Among Hispanic and Non-Hispanic White (NHW) Outpatient Clinic Patients With Osteoarthritis in Albuquerque, NM,
2001–2002
Any CAM 1.18 (0.59-2.36) 1.24 (0.60-2.58) 1.05 (0.57-1.95)
Nutritional supplements 0.82 (0.41-1.63) 0.52 (0.26-1.05) 0.63 (0.34-1.18)
Vitamins and minerals 1.73 (0.65-4.60) 1.64 (0.62-4.37) 0.95 (0.37-2.41)
Oral herbs 2.61 (0.88-7.70) 3.99 (1.48-10.7) 1.53 (0.52-4.47)
Herbal topical rubs 1.39 (0.66-2.96) 1.48 (0.68-3.22) 1.06 (0.48-2.33)
Items worn 4.95 (1.75-14.0) 4.68 (1.45-15.1) 0.95 (0.25-3.54)
Mind-body therapies 0.81 (0.34-1.93) 0.89 (0.37-2.18) 1.11 (0.53-2.32)
Energy therapies 0.69 (0.21-2.28) 3.37 (0.93-12.2) 4.89 (1.57-15.2)
Movement therapies 0.18 (0.03-0.98) 0.31 (0.06-1.65) 1.71 (0.58-5.07)
CAM therapists 1.63 (0.45-5.83) 1.72 (0.52-5.63) 1.06 (0.38-2.94)
Dietary approaches 3.83 (0.91-16.0) 1.36 (0.34-5.40) 0.35 (0.08-1.49)
OR indicates odds ratio; CI, confidence interval.
aModel covariates are age, sex, income, education, duration of disease, pain index (27), disability index (24), Arthritis Helplessness Index (25), and medical
skepticism scale (26).
bAcculturation status was determined using a five-item scale that measured the extent of use of Spanish, English, or both languages in day-to-day life.
Acculturation scores ranged from 5 (speaking, reading, and thinking in Spanish only) to 25 (speaking, reading, and thinking in English only) with a median of
15. Hispanics were classified as low acculturated if they scored at or below the median, and as high acculturated if they scored above the median.
cReference group.
14 Centers for Disease Control and Prevention • www.cdc.gov/pcd/issues/2006/jul/05_0231.htm
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services,
the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions. Use of trade names is for identification only
and does not imply endorsement by any of the groups named above.
Category of CAM Low Acculturation, % High Acculturation, % Pearson Chi-Square P Value
Low-Acculturated Hispanic Compared  Low-Acculturated Hispanic Compared  High-Acculturated Hispanic Compared
Category With High-Acculturated Hispanicc With Non-Hispanic Whitec With Non-Hispanic Whitec
of CAM OR (95% CI) OR (95% CI) OR (95% CI)Table 6. Communication With Primary Care Provider About Use of Complementary and Alternative Medicine (CAM) for
Osteoarthritis Among Primary Care Outpatients by Ethnic Group, Albuquerque, NM, 2001–2002, Percentages Weighted by
Inverse of Sampling Fraction
Patient told provider about CAM use 64.2 52.2 75.2 <.001
Provider reaction
Supportive provider reaction 38.5 27.7 45.5 .007
Passive approval 29.8 39.1 23.7 .02
Neutral or no reaction 16.1 13.0 18.1 .30
Disapproved 3.4 6.8 1.2 .06
Provider responded by recommending further  2.7 6.1 0.5 .01
conventional therapies
Reasons for telling provider about CAM use
Because provider asked about CAM use 22.7 26.0 20.5 .36
Important to inform provider 31.3 29.1 32.7 .58
Might affect treatment choices 16.1 15.4 16.6 .82
Get provider’s opinion 10.6 14.1 8.4 .18
Prevent drug interactions 7.6 4.9 9.3 .22
Reasons for not telling provider about CAM use
Provider did not ask 37.8 42.5 28.7 .21
Not important to tell provider 23.3 21.1 27.6 .52
aTable shows only open-ended responses given by at least 6% of one of the two ethnic groups.
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Total Sample,  Hispanic,  Non-Hispanic White,  Pearson 
Weighted % Weighted % Weighted % Chi-Square 
Communicationa (n = 422) (n = 218) (n = 204) P Value